Abstract
Here, we report the draft genome sequence of a methicillin-resistant Staphylococcus aureus (MRSA) strain with high-level mupirocin resistance (SA_ST125_MupR), isolated from a patient with recurrent bacteremia. This strain belonged to sequence type ST125, which was responsible for more than 50% of the health care-associated infections caused by MRSA in Spain.
Highlights
We report the draft genome sequence of a methicillin-resistant Staphylococcus aureus (MRSA) strain with high-level mupirocin resistance (SA_ST125_MupR), isolated from a patient with recurrent bacteremia
With increasing pressure to prevent MRSA infection, it is possible that there will be increased use of mupirocin for nasal decolonization of MRSA (3), which will be reflected in increased rates of resistance (4)
We detected 8.8% High-level mupirocin resistance (Hi-MupR) among MRSA isolates, and most of this resistance was focused on the ST125 clone (5)
Summary
We report the draft genome sequence of a methicillin-resistant Staphylococcus aureus (MRSA) strain with high-level mupirocin resistance (SA_ST125_MupR), isolated from a patient with recurrent bacteremia. Methicillin-resistant Staphylococcus aureus (MRSA) is among the most frequently identified antimicrobial drug-resistant pathogens worldwide. It has been demonstrated that some lineages are ecologically highly successful and that most isolates belong to pandemic clones (1).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.